메디
메디안디노스틱 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 나노헬릭스, was filed 09 Jan 2025.
메디안디노스틱: what insiders have been doing
메디안디노스틱 belongs to the Health Care sector. Filings by its managers are published through DART (FSS). Nothing new has been filed by managers of 메디안디노스틱 in twelve months, the latest record being from 9 January 2025.
For comparison within the same sector, see the insider buying recorded at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Insider Decl.
14
Thresholds
n/a
Buy Volume
n/a
7 ops. · all time
Sell Volume
n/a
5 ops. · all time
Who traded when
BuySale나노헬릭스4 buys
Sticprivateequityfundl.P.2 sales
오진식2 sales
Sticshariahprivateequityfundiiil.P.1 sale
Financial data
· cache
Last declaration on 9 January 2025
Declarations14 total
- ●Executives0DART
- 48,318 sharesShareKRXDART:20250109000278Canonical exit: 6 Apr 2025 (T+90)
- 48,318 sharesShareKRXDART:20250108000420
- ShareKRXDART:20241223000295
- ShareKRXDART:20241220000737
- 1,355,564 sharesKRXDART:20241220000718
- 102,670 sharesKRXDART:20241220000310Canonical exit: 18 Mar 2025 (T+90)
- ShareKRXDART:20241220000336Canonical exit: 18 Mar 2025 (T+90)
- ShareKRXDART:20241219000333
- 71,428 sharesKRXDART:20241216000293Canonical exit: 13 Mar 2025 (T+90)
- 10,250 sharesKRXDART:20241203000111Canonical exit: 25 Feb 2025 (T+90)
- 1,252,894 sharesKRXDART:20241107000266Canonical exit: 2 Feb 2025 (T+90)
- 0KRXDART:20241106000324
- 5,280 sharesShareKRXDART:20220321000891Canonical exit: 15 Jun 2022 (T+90)
14 of 14 declarations
About 메디안디노스틱
Median Diagnostics is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative medical diagnostics.
